Advancing research on the role of the gut in metabolic disease
Led by world renowned experts in metabolic disease, the EraseT2D task force shares Fractyl Health’s mission to build evidence, understand, and ultimately eradicate metabolic disease.
The Erase T2D task force builds on decades of discovery that have clearly identified the critical role of the gut as a regulator of metabolic disease. The signaling mechanisms between the gut and the rest of the body are numerous and not yet fully understood. The Erase Task Force is charged with advancing research on the role of the gut in metabolic disease to catalyze future discoveries that may inform how diabetes can be better understood and ultimately erased.
This initiative, funded by Fractyl Health, is meant to spur the kind of innovative thinking and fundamental breakthroughs that will point the way toward a world without type 2 diabetes.
Erase T2D Task Force
Alan Cherrington, Ph.D
Professor of Molecular Physiology & Biophysics, Professor of Medicine, and Jacquelyn A. Turner and Dr. Dorothy J Turner Chair in Diabetes Research at Vanderbilt University School of Medicine
Harith Rajagopalan, M.D., Ph.D.
Co-founder and CEO of Fractyl Health
Geltrude Mingrone, M.D., Ph.D.
Professor of diabetes and nutrition at King’s College, London; associate professor of internal medicine at Catholic University of Rome
Randy Seeley, Ph.D.
Professor of surgery and director of Michigan Nutrition Obesity Research Center at Michigan School of Medicine